A detailed history of Susquehanna International Group, LLP transactions in Geron Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 228,426 shares of GERN stock, worth $797,206. This represents 0.0% of its overall portfolio holdings.

Number of Shares
228,426
Previous 185,406 23.2%
Holding current value
$797,206
Previous $786,000 31.93%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.17 - $4.99 $179,393 - $214,669
43,020 Added 23.2%
228,426 $1.04 Million
Q2 2024

Aug 15, 2024

SELL
$3.1 - $5.09 $918,548 - $1.51 Million
-296,306 Reduced 61.51%
185,406 $786,000
Q1 2024

May 07, 2024

SELL
$1.75 - $3.44 $381,029 - $748,994
-217,731 Reduced 31.13%
481,712 $1.59 Million
Q4 2023

Feb 14, 2024

BUY
$1.74 - $2.31 $396,083 - $525,834
227,634 Added 48.25%
699,443 $1.48 Million
Q3 2023

Nov 14, 2023

SELL
$2.11 - $3.28 $568,668 - $883,996
-269,511 Reduced 36.36%
471,809 $1 Million
Q2 2023

Aug 11, 2023

SELL
$1.97 - $3.69 $984,988 - $1.84 Million
-499,994 Reduced 40.28%
741,320 $2.38 Million
Q1 2023

May 16, 2023

BUY
$2.14 - $3.4 $2.22 Million - $3.52 Million
1,036,400 Added 505.77%
1,241,314 $2.69 Million
Q4 2022

Feb 14, 2023

SELL
$2.03 - $2.42 $429,314 - $511,793
-211,485 Reduced 50.79%
204,914 $495,000
Q3 2022

Nov 14, 2022

BUY
$1.67 - $2.94 $513,688 - $904,338
307,598 Added 282.72%
416,399 $975,000
Q2 2022

Aug 15, 2022

SELL
$1.19 - $1.65 $70,165 - $97,288
-58,963 Reduced 35.15%
108,801 $169,000
Q1 2022

May 16, 2022

SELL
$0.99 - $1.6 $69,783 - $112,780
-70,488 Reduced 29.59%
167,764 $228,000
Q4 2021

Feb 14, 2022

BUY
$1.22 - $1.72 $10,029 - $14,140
8,221 Added 3.57%
238,252 $291,000
Q3 2021

Nov 15, 2021

BUY
$1.2 - $1.5 $1,124 - $1,405
937 Added 0.41%
230,031 $315,000
Q2 2021

Aug 11, 2021

BUY
$1.25 - $1.83 $131,892 - $193,090
105,514 Added 85.38%
229,094 $323,000
Q1 2021

May 17, 2021

SELL
$1.52 - $2.1 $339,212 - $468,648
-223,166 Reduced 64.36%
123,580 $195,000
Q4 2020

Feb 16, 2021

SELL
$1.55 - $2.05 $34,031 - $45,009
-21,956 Reduced 5.95%
346,746 $551,000
Q3 2020

Nov 16, 2020

BUY
$1.59 - $2.19 $224,027 - $308,566
140,898 Added 61.85%
368,702 $641,000
Q2 2020

Aug 14, 2020

SELL
$1.05 - $2.18 $265,847 - $551,949
-253,188 Reduced 52.64%
227,804 $497,000
Q1 2020

May 15, 2020

SELL
$0.89 - $1.49 $31,223 - $52,273
-35,083 Reduced 6.8%
480,992 $573,000
Q4 2019

Feb 14, 2020

SELL
$1.27 - $1.54 $122,068 - $148,020
-96,117 Reduced 15.7%
516,075 $702,000
Q3 2019

Nov 14, 2019

BUY
$1.15 - $1.59 $174,106 - $240,721
151,397 Added 32.86%
612,192 $814,000
Q2 2019

Aug 16, 2019

BUY
$1.37 - $2.02 $21,673 - $31,956
15,820 Added 3.56%
460,795 $650,000
Q2 2019

Aug 14, 2019

BUY
$1.37 - $2.02 $384,112 - $566,355
280,374 Added 170.34%
444,975 $627,000
Q1 2019

May 15, 2019

SELL
$1.01 - $1.83 $228,928 - $414,791
-226,662 Reduced 57.93%
164,601 $273,000
Q4 2018

Feb 14, 2019

SELL
$0.98 - $1.85 $749,318 - $1.41 Million
-764,611 Reduced 66.15%
391,263 $391,000
Q3 2018

Nov 14, 2018

BUY
$1.76 - $6.38 $1.83 Million - $6.63 Million
1,039,075 Added 889.63%
1,155,874 $2.03 Million
Q2 2018

Aug 14, 2018

SELL
$3.29 - $4.82 $141,552 - $207,380
-43,025 Reduced 26.92%
116,799 $401,000
Q1 2018

May 15, 2018

SELL
$1.81 - $5.98 $726,447 - $2.4 Million
-401,352 Reduced 71.52%
159,824 $679,000
Q4 2017

Feb 14, 2018

BUY
$1.8 - $2.32 $894,394 - $1.15 Million
496,886 Added 772.88%
561,176 $1.01 Million
Q3 2017

Nov 14, 2017

BUY
$1.99 - $2.65 $127,937 - $170,368
64,290
64,290 $140,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.32B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.